跳转至内容
Merck
CN

SML0041

巴马司他

≥98% (HPLC), powder, matrix metalloproteinase inhibitor

别名:

BB-94;(2R,3S)-N4- 羟基-N1-[(1S)-2-(甲基氨基)-2-氧代-1-(苯甲基)乙基] -2-(2-甲基丙基)-3-[(2-噻吩基硫基基)甲基] 丁二酰胺

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C23H31N3O4S2
化学文摘社编号:
分子量:
477.64
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

巴马司他, ≥98% (HPLC)

SMILES string

CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc2cccs2)C(=O)NO

InChI key

XFILPEOLDIKJHX-QYZOEREBSA-N

InChI

1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1

assay

≥98% (HPLC)

form

powder

color

white to tan

solubility

DMSO: ≥15 mg/mL

shipped in

wet ice

storage temp.

−20°C

Quality Level

Application

巴马司他已在多种研究中被用于抑制基质金属蛋白酶(MMP)的活性。

Biochem/physiol Actions

巴马司他是一种有效的广谱基质金属蛋白酶(MMP)抑制剂。
巴马司他是基质金属蛋白酶(MMP)的异羟肟酸类抑制剂。它抑制小鼠模型中肺肿瘤的生长和扩散,乳腺癌再生和人结肠肿瘤的生长和扩散。巴马司他降低 MMP 介导的血管功能障碍和血管壁损伤,并增强牙科粘合剂的密封性能和粘合强度。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Crotalus atrox disintegrin reduces hemorrhagic transformation by attenuating matrix metalloproteinase-9 activity after middle cerebral artery occlusion in hyperglycemic male rats
McBride DW, et al.
Journal of Neuroscience Research (2018)
Ursula Mirastschijski et al.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 18(2), 223-234 (2010-04-23)
The ability to regulate wound contraction is critical for wound healing as well as for pathological contractures. Matrix metalloproteinases (MMPs) have been demonstrated to be obligatory for normal wound healing. This study examined the effect that the broad-spectrum MMP inhibitor
S100A4 elevation empowers expression of metastasis effector molecules in human breast cancer
Ismail TM, et al.
Cancer Research, 77(3), 780-789 (2017)
M M Bildt et al.
Journal of periodontal research, 44(2), 266-274 (2008-11-01)
Orthodontic tooth movement requires remodeling of the periodontal tissues. The matrix metalloproteinases (MMPs) degrade the extracellular matrix components of the periodontal ligament, while the tissue inhibitors of metalloproteinases (TIMPs) control their activity. Synthetic MMP inhibitors have been developed to inhibit
G W Sledge et al.
Journal of the National Cancer Institute, 87(20), 1546-1550 (1995-10-18)
Matrix metalloproteinases (MMPs) are involved in the invasion and metastasis of human cancers by mediating the degradation of extracellular matrix components. Therefore, these enzymes constitute promising targets in the development of anticancer therapies. Batimastat ([(4-N-hydroxyamino)-2R-isobutyl-3S-(thienyl-thiomethyl)succinyl]-L- phenyl-alanine-N-methylamide) is one of a

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持